E. Elefante1, S. Monti2, M. Bond3, G. Lepri4, L. Quartuccio5, R. Talarico6, C. Baldini7
2017 Vol.35, N°1 ,Suppl.103 - PI 0005, PF 0026
One year in review
Free to view (click on article PDF icon to read the article)
This article is also available as an online CME course. The course has been granted 5 (five) CME credits.
The registration and fruition of the online course is free of charge, the fee of EURO 25.00 (=20.49 + VAT) must be paid in order to obtain the credits.
This activity is valid for credit from June 24, 2017 through May 14, 2018.
Systemic vasculitis is a group of heterogeneous, disabling disorders. Great interest has recently arisen in pathophysiology, clinical phenotypes and therapy of large- and small-vessel vasculitis. The general work hypothesis has been to promote research focused on disease-related pathogenetic pathways, with the ultimate goal of identifying novel diagnostic and prognostic biomarkers, thus leading towards more effective targeted treatments. Following the previous annual reviews of this series, we will hereby provide a critical digest of the recent literature on small- and large-vessel systemic vasculitis, with a specific focus on novel possible disease-related biomarkers and their impact on current and future therapies.
PMID: 28375840 [PubMed]
Received: 28/02/2017 - Accepted : 28/02/2017 - In Press: 29/03/2017 - Published: 19/04/2017